TrialScientific reports2020

Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.

Yong Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.